Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies, based in Elstree, UK, announced today it has received orphan drug marketing authorization for Coagadex® in Mexico.
A commitment for life
Who We Are
Recognising the importance of plasma and with over 60 years of experience in the industry, BPL supplies high-quality plasma-derived medicines to meet the needs of clinicians, patients and customers globally.
Therapy Areas & Products
BPL manufactures a wide range of products from blood plasma. These products fall broadly into three main therapy areas: immunology, critical care and coagulation disorders. The safety and quality of these plasma products is supported by BPL’s Quality Management Framework.
R&D
BPL’s R&D mission is to provide scientific and technical expertise to execute new product pipeline initiatives on time and to discover new products for commercialisation in order to provide a future for the business.
BPL’s commitment to quality is allied to its longstanding investment in its underlying scientific knowledge-base and R&D capability, led by the team of specialists in plasma therapies based in Elstree.
More about R&DResponsibility
BPL is focused on embracing its environmental, social and governance responsibilities.
BPL is committed to ensuring high standards of governance are maintained across the business, and is increasing its efforts to minimise its environmental impact.
More about responsibilityFeatured News
BPL receives orphan drug marketing authorization for Coagadex® in Mexico
04 May 2022
BPL Plasma opens its 29th donor centre
22 April 2022
Bio Products Laboratory Ltd (BPL), a leading manufacturer of plasma-derived protein therapies, are pleased to announce that on 22 April, BPL Plasma opened its 29th plasma donation centre.
BPL Celebrates World Hemophilia Day 2022
17 April 2022
Bio Products Laboratory Ltd (BPL), a leading manufacturer of plasma-derived protein therapies, joins the global bleeding disorders community in recognition of World Hemophilia Day (WHD). Observed annually on 17 April, WHD honours Frank Schnabel’s birthday, a person who suffered from severe hemophilia, and subsequently established the World Federation of Hemophilia (WFH).
Careers
We offer excellent career opportunities across our departments.
Vacancies
Whether we have an open vacancy right now or not, we would love to hear from you.
Apprenticeships
Our Apprenticeship opportunities are a great way to kickstart your career.